SCHW · DEEP VALUE BRIEFING

The Charles Schwab Corporation (SCHW)

published Oct 15, 2026 · price now $96.72 · market cap $175B

WATCH · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Verdict: WATCH, with an optional small starter position.

Charles Schwab is a high-quality financial franchise with scale, sticky client relationships, strong asset gathering, and meaningful operating leverage. At $96.80 and 17.5× trailing earnings, the shares are not plainly overpriced, but the evidence does not yet establish a sufficient discount to normalized intrinsic value.

The central uncertainty is not customer retention but customer monetization: Schwab may retain cash-sorting clients while earning structurally less spread income. The supplied data also omit the most important financial-company measures—deposit trends, supplemental borrowing, funding costs, regulatory capital, liquidity, securities duration, and parent distribution capacity.

The prior plan remains directionally sound, but it should be less binary. Investors should not wait for perfect confirmation or insist on an arbitrary price in the low $80s. A diversified, multi-year investor may initiate 25%–33% of the intended position, while reserving most capital for either fundamental confirmation or a lower price without business deterioration.


Assessment of the Analysts

Risky Analyst: Strong on opportunity cost, aggressive on valuation

The Risky Analyst correctly emphasizes that Schwab’s client relationship is the scarce asset. Clients moving cash into Schwab money-market funds generally remain within the ecosystem, preserving opportunities to earn advisory, asset-management, custody, trading, and retirement revenue. The analyst is also right that financial stocks often rerate before balance-sheet normalization becomes obvious.

Additional bullish evidence includes:

  • 22% year-over-year revenue growth
  • 17.9% ROE
  • 1.8% ROA
  • Potential TD Ameritrade cost savings and cross-selling
  • A 15.5% decline from the August high, reducing some prior optimism
  • Defensive options positioning, suggesting the recovery is not crowded

However, the proposed $124 value stacks two favorable assumptions: EPS reaching $6.50 and the market assigning a 19× multiple. At a more restrained 17× multiple, $6.50 of EPS supports approximately $111, only about 15% above the current price. The analyst also overstates the usefulness of the reported 32.2% ROIC, which is not a reliable industrial-style profitability measure for a broker-bank.

The suggestion to use call spreads is poorly aligned with a long-duration normalization thesis. Options add expiration risk and elevated implied-volatility costs to a situation where timing is especially uncertain.

Safe Analyst: Correct on financial risks, too willing to sacrifice optionality

The Safe Analyst identifies the debate’s most important weakness: the available data do not establish how much reported earnings are safely distributable.

Cash sorting may represent a persistent behavioral shift. Clients who learned to optimize idle cash may not return fully to low-yield sweep deposits. Schwab can therefore retain the relationship while suffering weaker spread economics. This supports the distinction between a strong retention moat and a less certain monetization moat.

The Safe Analyst is also correct that:

  • The 22% revenue increase may partly reflect recovery from a depressed period.
  • Technology, cybersecurity, compliance, and integration spending are not all discretionary growth investments.
  • TD Ameritrade creates execution and service risks as well as synergies.
  • Weak technicals and elevated put demand do not prove undervaluation.
  • Rate sensitivity cannot be considered resolved without evidence on funding composition and repricing.

The weakness is excessive price anchoring. Waiting specifically for the low-to-mid $80s assumes that price can decline while fundamentals remain unchanged. If the stock reaches $83 because capital, flows, or normalized earnings have deteriorated, the lower quotation may not provide a better investment. Conversely, if normalization continues, that entry may never appear.

Neutral Analyst: Best balance of uncertainty and opportunity cost

The Neutral Analyst offers the strongest practical framework: retain WATCH while permitting a small equity position.

This approach recognizes that the current risk/reward is approximately balanced rather than clearly unfavorable:

  • $110 base value: approximately 14% upside
  • $83 downside case: approximately 14% downside
  • $124 bullish case: approximately 28% upside, but dependent on favorable earnings and multiple assumptions

A starter allocation preserves participation if the market anticipates normalization before all evidence becomes conclusive. Reserving most capital protects against the possibility that cash sorting, funding costs, or regulatory constraints prove more persistent.

This is preferable to both immediate full accumulation and complete inactivity.


Risk Judge’s Rationale

1. Franchise quality is high, but earnings predictability is not yet equally high

Schwab has durable advantages:

  • Scale and brand trust
  • Embedded brokerage and retirement relationships
  • Adviser custody infrastructure
  • Switching friction involving records, workflows, taxes, and automated transactions
  • Multiple monetization channels across brokerage, advice, banking, and asset management

These characteristics materially reduce permanent franchise risk. Schwab should not be treated as an impaired regional bank merely because it has rate-sensitive earnings.

Nevertheless, the balance sheet is integral to the business model. Schwab’s value depends not only on gathering assets but on funding those assets economically and converting earnings into capital available to shareholders. That conversion remains insufficiently documented.

2. The valuation is reasonable, not demonstrably cheap

At $96.80 and 17.47× trailing earnings, implied trailing EPS is approximately $5.54. The multiple is defensible for a strong franchise, but it does not independently provide a margin of safety.

A wonderful business can justify only a 10%–15% discount to intrinsic value when cash flows are highly predictable. Here, the apparent discount to the roughly $110 base value is about 12%, but confidence in normalized owner earnings is not yet strong enough to apply the lowest quality-scaled discount requirement.

The bullish $124 case is plausible, but not adequately established. The $83 case is also plausible. That balanced distribution supports measured exposure rather than full advocacy.

3. Cash sorting is the key structural issue

The bull case correctly notes that clients often remain at Schwab. But retained assets do not necessarily preserve prior economics.

The critical questions are:

  • How much cash returns to bank deposits as rates change?
  • What fees does Schwab earn when cash stays in money-market products?
  • How quickly can expensive supplemental funding decline?
  • Can net interest revenue recover without aggressive deposit pricing or greater duration risk?

If Schwab retains relationships but permanently earns less on customer cash, normalized earnings may remain below bullish expectations even while client assets grow.

4. Missing balance-sheet evidence prevents an ADVOCATE rating

For Schwab, current ratios, quick ratios, gross margin, and conventional industrial ROIC are not decision-useful. The necessary measures include:

  • Bank deposit composition and sequential trends
  • Supplemental borrowing and its cost
  • Net interest margin and net interest revenue
  • Regulatory capital ratios
  • Liquidity at the banks and parent company
  • Securities duration and unrealized losses
  • Parent-company distribution capacity
  • Sustainable repurchase and dividend capacity

There is no supplied evidence of genuine distress, so AVOID would be excessive. But the missing information is central enough to prevent ADVOCATE.

5. Technical and options weakness should guide sizing, not determine intrinsic value

The roughly 15.5% pullback, weak intermediate trend, put/call volume ratio of 1.63, and elevated put implied volatility indicate concern. They do not establish either permanent impairment or undervaluation.

The Broadcom post-mortem provides the relevant lesson: technical weakness in a quality franchise should not automatically force complete inactivity. Conversely, Schwab differs from an asset-light secular technology leader because its balance sheet and funding structure directly affect intrinsic value. A staged position is therefore more appropriate than either chasing or waiting for perfect certainty.


Refined Investor Plan

Original plan

The original plan was to keep Schwab on WATCH, upgrade after funding and capital normalization, or buy in the low-to-mid $80s if fundamentals remained intact.

Improved plan

1. Initial exposure

For a diversified investor with a multi-year horizon:

  • Initiate 25%–33% of the intended long-term position at or around $96.80.
  • A reasonable initial portfolio allocation is approximately 0.5%–1.0%.
  • Keep the eventual position around 2%–3% or less, depending on existing exposure to banks, brokers, and asset managers.
  • Use equity rather than short- or medium-dated options.

Investors requiring a wider margin of safety may remain entirely on WATCH, but should avoid anchoring to one predetermined price.

2. Add on fundamental confirmation

Increase the position if several of the following occur over multiple reporting periods:

  • Seasonally adjusted deposits stabilize.
  • Supplemental borrowing declines.
  • Funding costs fall relative to asset yields.
  • Net interest revenue improves without aggressive deposit pricing.
  • Organic net new assets and adviser retention remain healthy.
  • Regulatory capital and parent liquidity remain comfortably adequate.
  • TD Ameritrade attrition stays limited.
  • Integration savings emerge without deteriorating service.
  • Normalized earnings grow at least in the mid-single digits.
  • Distributable earnings conversion is demonstrably above roughly 70%.

3. Add on valuation—but only if the thesis remains intact

A decline into the mid-to-high $80s could justify a larger purchase if asset flows, capital, liquidity, and funding trends have not deteriorated.

Do not average down merely because the stock is cheaper. A lower price caused by structural deposit losses or capital pressure is not automatically a margin of safety.

4. Upgrade to ADVOCATE

An ADVOCATE rating would become appropriate if either:

  • The price remains near current levels while funding, capital, and distributable earnings materially improve; or
  • The price falls sufficiently to create an approximately 20% or better discount to a conservatively supported intrinsic value without thesis deterioration.

5. Move toward AVOID

Reduce or exit if:

  • Organic net new assets weaken materially.
  • Client or adviser attrition becomes persistent.
  • Supplemental funding remains elevated or rises again.
  • Net interest economics fail to improve across a favorable normalization period.
  • Regulatory capital or parent liquidity becomes constrained.
  • TD Ameritrade integration causes sustained service problems or unexpected costs.
  • Normalized EPS appears unable to grow around 5% over the cycle.
  • Management pursues yield or duration risk to defend near-term earnings.

Continuous-Improvement Lessons

The key lesson from the earlier Broadcom miss is not to let valuation uncertainty create total paralysis in a high-quality franchise. A starter position can preserve upside while valuation and fundamentals determine final sizing.

The lesson from the successful Sea WATCH call is equally important: apparent cheapness is a hypothesis until earnings quality and cash conversion are verified. For Schwab, the relevant verification must come from financial-company metrics, not generic ratios.

Thus, the improved decision is neither full advocacy nor passive waiting. It is a disciplined WATCH with limited initial exposure, explicit confirmation triggers, and substantial dry powder.

STANCE: WATCH

Scorecard

Overall 4.32 out of 5, weighted as shown.

DimensionWeightScoreWhat it measures
Business Quality30%3.75 / 5High returns, profitability, and Piotroski health support durability.
Valuation Support30%4.33 / 5Blends current price against available intrinsic value anchors and valuation ratios.
Financial Strength20%4.50 / 5Balance-sheet resilience reflects leverage and liquidity staying within safe ranges.
Growth Durability20%5.00 / 5Recent revenue, earnings, and free cash flow growth indicate how durable expansion looks.

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 14, 2026; the market price was $96.72. Values are estimates, not predictions.

Owner earnings (Buffett)

Discounts owner earnings: the cash the business generates for its owners after the spending needed to keep it running.

Value per share: $53.69 / $76.71 / $76.71 (conservative / base / optimistic)

Starting Owner Earnings$5.2B
Growth: conservative / base / optimistic (2013–2023)10.0% / 10.0% / 10.0%
Projection10 years
Discount rate8.6%
Terminal growth2.5%
Shares outstanding1739M
The history the growth rates come from (13 years)
2011$1.1B
2012$1.2B
2013$1.3B
2014$1.4B
2015$1.7B
2016$2.2B
2017$2.7B
2018$3.2B
2019$3.4B
2020$3.1B
2021$5.6B
2022$6.9B
2023$5.0B

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $12.69 / $175.76 / $338.18 (conservative / base / optimistic)

Starting Free Cash Flow$10.4B
Growth: conservative / base / optimistic (2020–2025)-84.2% / 11.0% / 30.0%
Projection10 years
Discount rate9.3%
Terminal growth4.5%
Shares outstanding1739M
The history the growth rates come from (15 years)
2011$2.2B
2012$1.0B
2013$1.3B
2014$1.8B
2015$845M
2016$3.1B
2017−$1.4B
2018$11.7B
2019$8.4B
2020$6.0B
2021$948M
2022$720M
2023$18.6B
2024$1.7B
2025$8.4B

This briefing is from Oct 15, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

產生最新簡報 →Get the iPhone app

週一價值信

每週一封:傑出價值投資者買了什麼、賣了什麼,以及我們的看法。

請每週寄送一封 DeepValues 週一價值信給我。我可以隨時取消訂閱。僅供參考,不構成投資建議。 隱私政策